Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Natural killer (NK) cells attack tumor and infected cells, but the receptors and ligands that stimulate them are poorly understood. Here we report the expression cloning of two murine ligands for the lectin-like receptor NKG2D. The two ligands, H-60 and Rae1 beta, are distant relatives of major histocompatibility complex class I molecules. NKG2D ligands are not expressed by most normal cells but are up-regulated on numerous tumor cells. We show that mouse NKG2D is expressed by NK cells, activated CD8+ T cells and activated macrophages. Expression of either NKG2D ligand by target cells triggers NK cell cytotoxicity and interferon-gamma secretion by NK cells, as well as nitric oxide release and tumor necrosis factor alpha transcription by macrophages. Thus, through their interaction with NKG2D, H-60 and Rae1 beta are newly identified potent stimulators of innate immunity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Previous studies from our laboratory demonstrated that transplanted tumor cells expressing NKG2D ligands are rejected by NK cells and, in some cases, T cells (Diefenbach et al., 2000, 2001, 2003)”
From p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells (2013) · cites this paper as Diefenbach et al., 2000
Citations
Cites
Selective extraction of polyoma DNA from infected mouse cell cultures
Hirt, B. (1967) · Journal of Molecular Biology · doi:10.1016/0022-2836(67)90307-5 · Cited by 5,146 · cited 1×
“The extrachromosomal DNA was extracted from the sorted cells as describe”
MethodPhenotypic Analysis of Antigen-Specific T Lymphocytes
Altman, J. D., Moss, P. A. H., Goulder, P. J. R., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J., & Davis, M. M. (1996) · Science · doi:10.1126/science.274.5284.94 · Cited by 3,544 · cited 1×
“The recombinant protein was purified from inclusion bodies and refolded in vitro as describe”
MethodActivation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA
Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L., & Spies, T. (1999) · Science · doi:10.1126/science.285.5428.727 · Cited by 2,999 · cited 1×
“The MHC-encoded proteins MICA and the closely related MICB are distantly related to MHC class I protein”
BackgroundBiology of Natural Killer Cells
Trinchieri, G. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60664-1 · Cited by 2,902 · cited 2×
“(a) Stably transfected CHO cells expressing high levels of NKG2D-DAP10 (filled histograms), NKG2A-CD94 (2) or NKG2C-CD94 (3) as well as untransfected control cells (1) were stained with the absorbed antiserum against mNKG2D.”
MethodIn search of the ‘missing self’: MHC molecules and NK cell recognition
Ljunggren, H.-G., & Kärre, K. (1990) · Immunology Today · doi:10.1016/0167-5699(90)90097-s · Cited by 2,687 · cited 4×
“(a) Stably transfected CHO cells expressing high levels of NKG2D-DAP10 (filled histograms), NKG2A-CD94 (2) or NKG2C-CD94 (3) as well as untransfected control cells (1) were stained with the absorbed antiserum against mNKG2D.”
MethodInfluentialProduction of high-titer helper-free retroviruses by transient transfection.
Pear, W. S., Nolan, G. P., Scott, M. L., & Baltimore, D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8392 · Cited by 2,266
Lanier, L. L. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.359 · Cited by 1,648 · cited 4×
“(a) Stably transfected CHO cells expressing high levels of NKG2D-DAP10 (filled histograms), NKG2A-CD94 (2) or NKG2C-CD94 (3) as well as untransfected control cells (1) were stained with the absorbed antiserum against mNKG2D.”
MethodInfluentialAn Activating Immunoreceptor Complex Formed by NKG2D and DAP10
Wu, J., Song, Y., Bakker, A. B. H., Bauer, S., Spies, T., Lanier, L. L., & Phillips, J. H. (1999) · Science · doi:10.1126/science.285.5428.730 · Cited by 1,039 · cited 1×
“Recent evidence indicates that human NKG2D forms a homodimer that associates with the signaling subunit DAP10 on the surface of NK cells and CD8 + T cell”
BackgroundBroad tumor-associated expression and recognition by tumor-derived γδ T cells of MICA and MICB
Groh, V., Rhinehart, R., Secrist, H., Bauer, S., Grabstein, K. H., & Spies, T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6879 · Cited by 1,028
Groh, V, Bahram, S., Bauer, S., Herman, A., Beauchamp, M., & Spies, T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.22.12445 · Cited by 1,017 · cited 1×
“MICA and MICB are normally expressed on a subset of intestinal epithelial cells, but their expression is up-regulated by cellular stres”
Background
Research works printed but not linked: 2
- Cosman, D. et al. The human cytomegalovirus (HCMV) glycoprotein, UL16, binds to the MHC class I-related protein, MICB/PERB11, and to two novel, MHC class I-related molecules, ULBP1 and ULBP2. FASEB J. 14, A1018 (2000).
- Chalupny, J. et al. Soluble forms of the novel MHC class I–related molecules, ULBP1 and ULBP2, bind to, and functionally activate NK cells. FASEB J. 14, A1018 (2000).
Cited by
Items 201–300 of 875
Natural killer cells and innate immunity to protozoan pathogens
Korbel, D. S., Finney, O. C., & Riley, E. M. (2004) · International Journal for Parasitology · doi:10.1016/j.ijpara.2004.10.006 · Cited by 147
Genetics, genomics, and evolutionary biology of NKG 2D ligands
Carapito, R., & Bahram, S. (2015) · Immunological Reviews · doi:10.1111/imr.12328 · Cited by 130
“The Rae-1 (retinoic acid early) subfamily was discovered, prior to their human counterpart, as genes upregulated by retinoic acid in F9 embryonic cells (42) and their products were identified as ligands for NKG2D a few years later (43, 44).”
BackgroundULBP6/RAET1L is an additional human NKG2D ligand
Eagle, R. A., Traherne, J. A., Hair, J. R., Jafferji, I., & Trowsdale, J. (2009) · European Journal of Immunology · doi:10.1002/eji.200939502 · Cited by 148
New prospects on the NKG2D/NKG2DL system for oncology
Ullrich, E., Koch, J., Cerwenka, A., & Steinle, A. (2013) · OncoImmunology · doi:10.4161/onci.26097 · Cited by 127
Perturbation of NK cell peripheral homeostasis accelerates prostate carcinoma metastasis
Liu, G., Lu, S., Wang, X., Page, S. T., Higano, C. S., Plymate, S. R., Greenberg, N. M., Sun, S., Li, Z., & Wu, J. D. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69369 · Cited by 127
“To clarify the impact of human NKG2D ligands on cancer, we exploited the knowledge that the human NKG2D ligand MICB can stimulate mouse NKG2D immunity (33, 34) and generated 2 unique lines of “humanized” bi-transgenic (bi-Tg) mouse models, TRAMP/MICB and TRAMP/MICB.”
IELs: enforcing law and order in the court of the intestinal epithelium
Cheroutre, H. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00284.x · Cited by 118
“previously discussed RA inducible RAE-1 molecule, that can bind to these activating NK receptors (147, 194).”
BackgroundThe NKG2D receptor: sensing stressed cells
López‐Larrea, C., Suárez-Álvarez, B., López‐Soto, A., López‐Vázquez, A., & Gonzalez, S. R. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.02.004 · Cited by 128
The Role of NK Cells in Autoimmune Disease
Baxter, A. G., & Smyth, M. J. (2002) · Autoimmunity · doi:10.1080/08916930290005864 · Cited by 125
Molecular competition for NKG2D: H60 and RAE1 compete unequally for NKG2D with dominance of H60.
O'Callaghan, C., Cerwenka, A., Willcox, B. E., Lanier, L., & Bjorkman, P. (2001) · Immunity · doi:10.1016/s1074-7613(01)00187-x · Cited by 142
NK Cells in HIV-1 Infection: From Basic Science to Vaccine Strategies
Flórez‐Álvarez, L., Hernández, J. C., & Zapata, W. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02290 · Cited by 123
Blockade of NKG2D on NKT cells prevents hepatitis and the acute immune response to hepatitis B virus
Vilarinho, S., Ogasawara, K., Nishimura, S., Lanier, L. L., & Baron, J. L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708968104 · Cited by 114
Tissue-Resident NK Cells: Development, Maturation, and Clinical Relevance
Hashemi, E., & Malarkannan, S. (2020) · Cancers · doi:10.3390/cancers12061553 · Cited by 135
“Induced self-ligands include non-classical major histocompatibility complex class I [46] such as human MIC-A, MIC-B [39,47–51], and murine H60 [45,52,53], Rae (α-ε) [54], and Mult-1 [55,56].”
BackgroundTumor-associated neutrophils suppress antitumor immunity of NK cells through the PD-L1/PD-1 axis
Sun, R., Xiong, Y.-Y., Liu, H., Gao, C., Su, L., Weng, J., Yuan, X., Zhang, D., & Feng, J. (2020) · Translational Oncology · doi:10.1016/j.tranon.2020.100825 · Cited by 119
Selective Down-Regulation of the NKG2D Ligand H60 by Mouse Cytomegalovirus m155 Glycoprotein
Hasan, M., Krmpotić, A., Ruzsics, Z., Bubić, I., Roviš, T. L., Halenius, A., Loewendorf, A. I., Messerle, M., Hengel, H., Jonjić, S., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.5.2920-2930.2005 · Cited by 126
“The known NKG2D ligands on human cells are the MHC class I chain-related molecules (MICA and MICB) (6, 47) and the UL-16 binding proteins (ULBP-1, ULBP-2, and ULBP-3) (12), whereas the mouse NKG2D ligands are H60 (15, 30), retinoic acid early inducible gene 1 (RAE-1 , - , - , - , and -ε isoforms) (10), and the recentl…”
BackgroundInfluentialMalarkannan, S., Horng, T., Eden, P. A., Gonzãlez, F., Shih, P. P., Brouwenstijn, N., Klinge, H., Christianson, G. J., Roopenian, D. C., & Shastri, N. (2000) · Immunity · doi:10.1016/s1074-7613(00)00033-9 · Cited by 116
Self-citationThe emerging role of Epstein-Barr virus encoded microRNAs in nasopharyngeal carcinoma
Fan, C., Tang, Y., Wang, J., Xiong, F., Guo, C. J., Wang, Y., Xiang, B., Zhou, M., Li, X., Wu, X., et al. (2018) · Journal of Cancer · doi:10.7150/jca.25460 · Cited by 113
“The NKG2D receptor is located on the surface of NK cells, can function in immune recognition in infected cells and effectively activate NK cells and T cells [23].”
BackgroundHe, W., Hao, J., Dong, S., Gao, Y., Tao, J., Chi, H., Flavell, R. A., O’Brien, R. L., Born, W. K., Craft, J. E., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903767 · Cited by 117
“The specificity of blocking NKG2D was confirmed by its effect on secondary staining with allophycocyanin–anti-mouse NKG2D as described (24).”
ULBPs, human ligands of the NKG2D receptor, stimulate tumor immunity with enhancement by IL-15
Sutherland, C. L., Rabinovich, B., Chalupny, N. J., Brawand, P., Miller, R., & Cosman, D. (2006) · Blood · doi:10.1182/blood-2005-11-011320 · Cited by 106
Acquired and natural memory T cells join forces at the mucosal front line
Cheroutre, H., & Madakamutil, L. T. (2004) · Nature reviews. Immunology · doi:10.1038/nri1333 · Cited by 109
Costimulation of Multiple NK Cell Activation Receptors by NKG2D
Ho, E. L., Carayannopoulos, L. N., Poursine-Laurent, J., Kinder, J., Plougastel, B., Smith, H. R. C., & Yokoyama, W. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.7.3667 · Cited by 105
“Many tumors constitutively express the ligands recognized by NKG2D, as indicated by a sNKG2D tetramer and flow cytometry (data not shown) (44, 46).”
BackgroundCrystal Structures of RAE-1β and Its Complex with the Activating Immunoreceptor NKG2D
Li, P., McDermott, G., & Strong, R. K. (2002) · Immunity · doi:10.1016/s1074-7613(02)00258-3 · Cited by 116
“D.H. (2000).”
Immunosurveillance and immunotherapy of tumors by innate immune cells
Iannello, A., Thompson, T. W., Ardolino, M., Marcus, A., & Raulet, D. H. (2016) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.11.001 · Cited by 105
Self-citationNatural Killer Cells: Tumor Surveillance and Signaling
Guzman, L. G. M., Keating, N., & Nicholson, S. E. (2020) · Cancers · doi:10.3390/cancers12040952 · Cited by 130
“ULBP1-6 have two extracellular α(1–2) domains and ULBP4 and 5 are similar to murine Rae1 ligands [191,209].”
Signal Transduction in Natural Killer Cells
Macfarlane, A. W., & Campbell, K. S. (2005) · Current topics in microbiology and immunology · doi:10.1007/3-540-27743-9_2 · Cited by 116
“that NKG2D/DAP10-mediated activation is apparently less sensitive to attenuation by MHC class I-binding inhibitory receptors, such as KIR, whereas ITAM-containing receptor signaling is readily blocked by these inhibitory receptors [10, 32, 44, 49].”
BackgroundZoonotic orthopoxviruses encode a high-affinity antagonist of NKG2D
Campbell, J. A., Trossman, D., Yokoyama, W., & Carayannopoulos, L. (2007) · Journal of Experimental Medicine · doi:10.1084/jem.20062026 · Cited by 110
“Consistent with the lack of NKG2D expression on resting mouse T cells (20), OMCPBR tetramers failed to bind freshly isolated splenic T cells.”
Yadav, D., Ngolab, J., Lim, R. S.-H., Krishnamurthy, S., & Bui, J. D. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.1.39 · Cited by 102
“NKG2D binds to a family of ligands whose expression is induced by viral infection, transformation, and cellular stress (3, 4).”
BackgroundBiochemical Features of the MHC-Related Protein 1 Consistent with an Immunological Function
Miley, M. J., Truscott, S. M., Yu, Y. Y. L., Gilfillan, S., Fremont, D. H., Hansen, T. H., & Lybarger, L. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.12.6090 · Cited by 104
“Not all immunologically effective class I-like molecules present Ag; for instance, the UL16-binding protein (8), retinoic acid early inducible and H60 (9, 10), MHC-I-related gene A/B (11), and murine UL16binding protein-like transcript 1 (12) molecules serve as ligands for NKG2D, an activating receptor expressed on NK…”
BackgroundEhrlich, L. I. R., Ogasawara, K., Hamerman, J. A., Takaki, R., Zingoni, A., Allison, J. P., & Lanier, L. L. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.4.1922 · Cited by 102
Regulation of NKG2D Ligand Gene Expression
Eagle, R. A., Traherne, J. A., Ashiru, O., Wills, M. R., & Trowsdale, J. (2006) · Human Immunology · doi:10.1016/j.humimm.2006.02.015 · Cited by 105
Guo, H., Samarakoon, A., Vanhaesebroeck, B., & Malarkannan, S. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072327 · Cited by 101
IFN-Dependent Down-Regulation of the NKG2D Ligand H60 on Tumors
Bui, J. D., Carayannopoulos, L. N., Lanier, L. L., Yokoyama, W. M., & Schreiber, R. D. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.2.905 · Cited by 101
The double life of NK receptors: stimulation or co-stimulation?
Snyder, M. R., Weyand, C. M., & Goronzy, J. J. (2003) · Trends in Immunology · doi:10.1016/j.it.2003.10.011 · Cited by 105
Role of NK and NKT cells in the immunopathogenesis of HCV-induced hepatitis
Ahmad, A., & Alvarez, F. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0304197 · Cited by 100
“This type of lysis may cause tissue damage and contribute toward pathogenesis of the infection, as these ligands are also induced on uninfected host cells as a result of stress and inflammatory mediators [85, 87].”
BackgroundBedel, R., Thiery-Vuillemin, A., Grandclément, C., Balland, J., Rémy-Martin, J.-P., Kantelip, B. M., Pallandre, J., Pivot, X. B., Ferrand, C., Tiberghien, P., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-09-4540 · Cited by 112
“MHC class I chain related A and B (MICA and MICB) or ULBP proteins (7, 10, 11) are NKG2DLs, weakly expressed on normal cells and up-regulated in cancers (12-16).”
Whang, M. I., Guerra, N., & Raulet, D. H. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802439 · Cited by 98
“The generation of the NKG2D tetramer and the staining protocol for this reagent were described previously (9).”
BackgroundMethodSelf-citationDeMarco, R., Fink, M. P., & Lotze, M. T. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.07.023 · Cited by 110
The NKG2D receptor: immunobiology and clinical implications
Burgess, S. J., Maasho, K., Masilamani, M., Narayanan, S., Borrego, F., & Coligan, J. E. (2007) · Immunologic Research · doi:10.1007/s12026-007-0060-9 · Cited by 114
“In contrast, anti-NKG2D-mediated stimulation of freshly isolated, resting murine NK cells alone leads to profound cytotoxic capabilities and cytokine production [47, 48].”
BackgroundLópez‐Botet, M., Angulo, A., & Gumá, M. (2004) · Tissue Antigens · doi:10.1111/j.1399-0039.2004.00210.x · Cited by 97
Posttranslational regulation of the NKG2D ligand Mult1 in response to cell stress
Nice, T. J., Coscoy, L., & Raulet, D. H. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081335 · Cited by 98
Self-citationA review on the role of M2 macrophages in bladder cancer; pathophysiology and targeting
Sharifi, L., Nowroozi, M. R., Amini, E., Kourosh‐Arami, M., Ayati, M., & Mohsenzadegan, M. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.105880 · Cited by 103
Chimeric NKG2D Receptor–Bearing T Cells as Immunotherapy for Ovarian Cancer
Barber, A., Zhang, T., DeMars, L. R., Conejo-Garcia, J. R., Roby, K. F., & Sentman, C. L. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4047 · Cited by 95
Thermodynamic Analysis of Degenerate Recognition by the NKG2D Immunoreceptor
McFarland, B. J., & Strong, R. K. (2003) · Immunity · doi:10.1016/s1074-7613(03)00320-0 · Cited by 95
“…addi- Strong, 2002). tional roles in innate immunity by driving the activation This extreme recognition degeneracy ( 1 versus 2 of macrophages (Diefenbach et al., 2000) and particular on a ligand protein, one ligand protein versus another, T cell populations (Das et al., 2001), and in…”
BackgroundUpshaw, J. L., & Leibson, P. J. (2006) · Seminars in Immunology · doi:10.1016/j.smim.2006.03.001 · Cited by 114
NKG2D and cytotoxic effector function in tumor immune surveillance
Hayakawa, Y., & Smyth, M. J. (2006) · Seminars in Immunology · doi:10.1016/j.smim.2006.03.005 · Cited by 106
Iannello, A., Débbeche, O., Samarani, S., & Ahmad, A. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0907650 · Cited by 98
“, heat shock, hypoxia, inflammation, TNF- , or IL-8), do not induce expression of NKG2D ligands [104–107].”
BackgroundInnate immune recognition by stimulatory immunoreceptors
Diefenbach, A., & Raulet, D. H. (2003) · Current Opinion in Immunology · doi:10.1016/s0952-7915(02)00007-9 · Cited by 108
Self-citationLee, K. (2005) · Blood · doi:10.1182/blood-2005-01-0185 · Cited by 93
Immune Activation Resulting From NKG2D/Ligand Interaction Promotes Atherosclerosis
Xia, M., Guerra, N., Sukhova, G. K., Yang, K., Miller, C. K., Shi, G., Raulet, D. H., & Xiong, N. (2011) · Circulation · doi:10.1161/circulationaha.111.034850 · Cited by 116
Self-citationChoi, E. Y., Christianson, G. J., Yoshimura, Y., Sproule, T. J., Jung, N., Joyce, S., & Roopenian, D. C. (2002) · Immunity · doi:10.1016/s1074-7613(02)00428-4 · Cited by 91
Dubrot, J., Lane-Reticker, S. K., Kessler, E. A., Ayer, A., Mishra, G., Wolfe, C. H., Zimmer, M. D., Du, P. P., Mahapatra, A., Ockerman, K. M., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.01.001 · Cited by 91
Conservation and Variation in Human and Common Chimpanzee CD94 and NKG2 Genes
Shum, B. P., Flodin, L. R., Muir, D. G., Rajalingam, R., Khakoo, S. I., Cleland, S., Guethlein, L. A., Uhrberg, M., & Parham, P. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.1.240 · Cited by 91
“Even more different are the divergent MHC class I-related ligands for NKG2D, which comprise MIC (24, 25) and ULBPs (47) in humans, and the retinoic acid early inducible RAE-1 and H60 in mice (62, 63).”
BackgroundThe pathological roles of BART miRNAs in nasopharyngeal carcinoma
Lo, A. K. F., Dawson, W. O., Jin, D., & Lo, K. W. (2012) · The Journal of Pathology · doi:10.1002/path.4025 · Cited by 99
The nonpolymorphic MHC Qa-1b mediates CD8+ T cell surveillance of antigen-processing defects
Oliveira, C., van Veelen, P. V., Querido, B. J., de Ru, A. H., Sluijter, M., Laban, S., Drijfhout, J., van der Burg, S., Offringa, R., & van Hall, T. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20091429 · Cited by 101
“A role for NKG2D was also not likely, as our RMA-based lymphoma panel lacks NKG2D ligands (Diefenbach et al., 2000).”
BackgroundDemaria, S., Pilones, K. A., Vanpouille‐Box, C., Golden, E. B., & Formenti, S. C. (2014) · Radiation Research · doi:10.1667/rr13500.1 · Cited by 95
“Conversely, the genomic instability associated with neoplastic transformation leads to the generation of neoantigens recognized by T cells (3), and to the expression of stress-induced ligands on cancer cells, for example members of the family of NKG2D ligands, which are recognized by natural killer (NK), cd T cells an…”
Takada, A., Yoshida, S., Kajikawa, M., Miyatake, Y., Tomaru, U., Sakai, M., Chiba, H., Maenaka, K., Kohda, D., Fugo, K., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.3.1678 · Cited by 89
“Subsequently, H60 molecules (referred to as H60a in this paper) were shown to function as a ligand for the mouse NKG2D receptor (11, 23).”
BackgroundMultifaceted roles of MHC class I and MHC class I–like molecules in T cell activation
Ugolini, S., & Vivier, É. (2001) · Nature Immunology · doi:10.1038/85246 · Cited by 89
Dendritic Cell-NK Cell Cross-Talk: Regulation and Physiopathology
Zitvogel, L., Terme, M., Borg, C., & Trinchieri, G. (2005) · Springer eBooks · doi:10.1007/3-540-27743-9_8 · Cited by 94
Hervieu, A., Rébé, C., Végran, F., Chalmin, F., Bruchard, M., Vabres, P., Apétoh, L., Ghiringhelli, F., & Mignot, G. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.273 · Cited by 97
“The expression of NKG2D ligands in cells that do not express them endogenously renders the cells more prone to NK cell–mediated lysis in vitro, and reduces the tumorigenicity of tumor cell lines in vivo (Cerwenka et al., 2000, 2001; Diefenbach et al., 2000, 2001).”
BackgroundBeyond Stressed Self: Evidence for NKG2D Ligand Expression on Healthy Cells
Eagle, R. A., Jafferji, I., & Barrow, A. D. (2009) · Current Immunology Reviews · doi:10.2174/157339509787314369 · Cited by 101
“In mice there is an even greater diversity of NKG2D ligands, with five retinoic acid early transcripts (RAE-1α-ε), three variants of the H60 minor histocompatibility antigen, and murine UL16-bindingprotein-like transcript-1 (MULT1) [12-15].”
BackgroundNatural killer cells in viral infection: more than just killers
Andoniou, C. E., Andrews, D. M., & Degli‐Esposti, M. A. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00465.x · Cited by 87
“Lenac T, et al. The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60.”
BackgroundInfluentialCrystal structure of the murine NK cell–activating receptor NKG2D at 1.95 Å
Wolan, D. W., Teyton, L., Rudolph, M. G., Villmow, B., Bauer, S., Busch, D. H., & Wilson, I. A. (2001) · Nature Immunology · doi:10.1038/85311 · Cited by 93
The NKG2D/NKG2DL Axis in the Crosstalk Between Lymphoid and Myeloid Cells in Health and Disease
Stojanovic, A., Correia, M. P., & Cerwenka, A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00827 · Cited by 93
ITAM-based signaling beyond the adaptive immune response
Fodor, S., Jakus, Z., & Mócsai, A. (2005) · Immunology Letters · doi:10.1016/j.imlet.2005.11.001 · Cited by 102
Natural killer cells and their receptors in multiple sclerosis
Kaur, G., Trowsdale, J., & Fugger, L. (2013) · Brain · doi:10.1093/brain/aws159 · Cited by 85
Endothelial cells express NKG2D ligands and desensitize antitumor NK responses
Thompson, T. W., Kim, A. B., Li, P. J., Wang, J., Jackson, B. T., Huang, K. T. H., Zhang, L., & Raulet, D. H. (2017) · eLife · doi:10.7554/elife.30881 · Cited by 90
“At the same time, our results support the classical view that NKG2D can participate in immune surveillance of cancer by recognizing NKG2D ligands on tumor cells to induce NK cell activation and tumor cell killing (Diefenbach et al., 2000; Cerwenka et al., 2001; Diefenbach et al., 2001; Jamieson et al., 2002; Guerra et…”
BackgroundResultSelf-citationTumor cell recognition by natural killer cells.
Long, E. O. (2002) · Seminars in Cancer Biology · doi:10.1006/scbi.2001.0398 · Cited by 86
Wesselkamper, S. C., Eppert, B. L., Motz, G. T., Lau, G. W., Hassett, D. J., & Borchers, M. T. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5481 · Cited by 101
Structure and Function of Natural Killer Cell Surface Receptors
Radaev, S., & Sun, P. D. (2003) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.32.110601.142347 · Cited by 102
Liu, Q., Smith, C. W., Zhang, W., Burns, A. R., & Li, Z. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.04.010 · Cited by 84
“The blocking antibody against NKG2D, an NK cell activation receptor, was used as an antibody-binding control.(47,48) This antibody blocks activation of NK cells through the NKG2D receptor,(44) but did not affect their migration to the cornea.”
MethodTamang, D., Redelman, D. D., Alves, B. N., Vollger, L. W., Bethley, C., & Hudig, D. (2006) · Cytokine · doi:10.1016/j.cyto.2006.11.008 · Cited by 84
“Marker Function Molecules involved in cytotoxicity: NKG2D Lectin-like cytotoxicity-activating receptor of activated CD8+ T cells and NK cells [40,41].”
BackgroundAn integrated view of the regulation of NKG2D ligands
Stern‐Ginossar, N., & Mandelboim, O. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03147.x · Cited by 82
The Warburg effect: molecular aspects and therapeutic possibilities
Ngo, H. G., Tortorella, S. M., Ververis, K., & Karagiannis, T. C. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3764-7 · Cited by 85
“NK cell can also interact with tumour cell via stress ligands on the surface of tumour cells [27].”
BackgroundResveratrol enhances perforin expression and NK cell cytotoxicity through NKG2D‐dependent pathways
Lu, C., & Chen, J. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22043 · Cited by 86
“Numerous studies supported the concept that NKG2D plays an important role in triggering IL-2-activated NK cells, as its ligation induces calcium flux, cytokine release, and cytotoxicity (Diefenbach et al., 2000; Castriconi et al., 2003; Zompi et al., 2003; Verneris et al., 2004).”
BackgroundVerma, C., Kaewkangsadan, V., Eremin, J. M., Cowley, G., Ilyas, M., El‐Sheemy, M., & Eremin, O. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0535-8 · Cited by 83
Choi, E. Y., Yoshimura, Y., Christianson, G. J., Sproule, T. J., Malarkannan, S., Shastri, N., Joyce, S., & Roopenian, D. C. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.7.4370 · Cited by 80
“NKG2D stimulatory receptors: however, it is not known whether this property impacts its immunodominance (21, 22).”
BackgroundSelf-citationThe NKG2D receptor and its ligands–recognition beyond the “missing self”?
Watzl, C. (2003) · Microbes and Infection · doi:10.1016/s1286-4579(02)00057-6 · Cited by 94
Intrinsic sensor of oncogenic transformation induces a signal for innate immunosurveillance
Unni, A. M., Bondar, T., & Medzhitov, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701675105 · Cited by 80
Chua, A. C. L., Hodson, L. J., Moldenhauer, L. M., Robertson, S. A., & Ingman, W. V. (2010) · Development · doi:10.1242/dev.059261 · Cited by 79
“Interaction between NKG2D on macrophages and these DNA damage-response ligands induces release of nitric oxide and production of TNF by macrophages, and is a mechanism by which the innate immune system eliminates potentially oncogenic cells (Diefenbach et al., 2000).”
BackgroundInfluentialPennington, D. J., Vermijlen, D., Wise, E. L., Clarke, S. L., Tigelaar, R. E., & Hayday, A. (2005) · Advances in immunology · doi:10.1016/s0065-2776(05)87002-6 · Cited by 91
Tsai, Y., Cheng, P.-C., Fan, C., & Pan, T. (2008) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2008.08.009 · Cited by 90
“NK cells are specialized lymphocytes of the innate immune system capable of attacking virus-infected cells or transformed tumor cells via NKG2D triggered NK cell-mediated cytotoxicity (Diefenbach et al., 2000).”
BackgroundThe nonpolymorphic MHC Qa-1b mediates CD8+ T cell surveillance of antigen-processing defects
Oliveira, C., van Veelen, P. V., Querido, B. J., de Ru, A. H., Sluijter, M., Laban, S., Drijfhout, J., van der Burg, S., Offringa, R., & van Hall, T. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.2009142922610c · Cited by 42
“A role for NKG2D was also not likely, as our RMA-based lymphoma panel lacks NKG2D ligands (Diefenbach et al., 2000).”
BackgroundCarapito, R., Jung, N., Kwemou, M., Untrau, M., Michel, S., Pichot, A., Giacometti, G., Macquin, C., Ilias, W., Morlon, A., et al. (2016) · Blood · doi:10.1182/blood-2016-05-719070 · Cited by 88
“…there is a peculiar precedent for this: the murine minor histocompatibility locus, H60, encodes an MHC-I-like structure that is a NKG2D ligand 43,44 ), we much favor the fi rst option, especially given that both NK and gd T are considered important effector cells that mediate GVL reactivity…”
The Activating Immunoreceptor NKG2D and Its Ligands Are Involved in Allograft Transplant Rejection
Kim, J., Chang, C. K., Hayden, T. A., Liu, F., Benjamin, J., Hamerman, J. A., Lanier, L. L., & Kang, S. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.10.6416 · Cited by 77
“A family of MHC class I-related proteins has been recently identified that is up-regulated by a variety of conditions such as cellular stress, heat shock, infection, DNA damage, or transformation (5, 6).”
BackgroundCytokine-Induced Killer Cells Eradicate Bone and Soft-Tissue Sarcomas
Sangiolo, D., Mesiano, G., Gammaitoni, L., Leuci, V., Todorovic, M., Giraudo, L., Cammarata, C., Dell’Aglio, C., D’Ambrosio, L., Pisacane, A. M., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1559 · Cited by 80
Terra, M. L., Oberkampf, M., Fayolle, C., Rosenbaum, P., Guillerey, C., Dadaglio, G., & Leclerc, C. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-2719 · Cited by 81
“This discrepancy between these two tumors could be linked to the lack of expression of NKG2D ligands by B16 tumors (44), leading to an inefficient killing by NK Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.”
BackgroundREVIEW ARTICLE: NK Cell Tolerance and the Maternal–Fetal Interface
Riley, J. K., & Yokoyama, W. M. (2008) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2008.00593.x · Cited by 78
Innate Immune Responses to LCMV Infections: Natural Killer Cells and Cytokines
Biron, C. A., Nguyen, K. B., & Pien, G. C. (2002) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-56055-2_2 · Cited by 76
Ogasawara, K., Yoshinaga, S. K., & Lanier, L. L. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.7.3676 · Cited by 87
“Since many tumors express NKG2D ligands (28, 29, 45), and certain tumors, especially leukemias, express the ICOS ligand (46), these costimulatory receptors may play important roles in immune surveillance against cancer.”
BackgroundStrategies of Natural Killer Cell Recognition and Signaling
Stewart, C. A., Vivier, É., & Colonna, M. (2005) · Current topics in microbiology and immunology · doi:10.1007/3-540-27743-9_1 · Cited by 84
“The NKG2D ligands MICA, MICB, and Rae1 are all upregulated in tumor cells (Cerwenka et al. 2000; Diefenbach et al. 2000; Groh et al. 1996).”
BackgroundThe multifaceted role of extracellular vesicles in metastasis: Priming the soil for seeding
dos Anjos Pultz, B., Andrés Cordero da Luz, F., Socorro Faria, S., Peixoto Ferreira de Souza, L., Cristina Brígido Tavares, P., Alonso Goulart, V., Fontes, W., Ricardo Goulart, L., & José Barbosa Silva, M. (2017) · International Journal of Cancer · doi:10.1002/ijc.30595 · Cited by 74
Borchers, M. T., Wesselkamper, S. C., Curull, V., Ramírez-Sarmiento, A., Sánchez‐Font, A., García‐Aymerich, J., Coronell, C., Lloreta, J., Agustí, A. G. N., Gea, J., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci34462 · Cited by 77
“Ligands for the mouse NKG2D receptor are encoded by the retinoic acid–inducible early genes (Raet1a–Raet1e) (19), H60 (20), and Mult1 (21).”
BackgroundHormonal Regulation of the Immune Microenvironment in the Mammary Gland
Need, E. F., Atashgaran, V., Ingman, W. V., & Dasari, P. (2014) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-014-9324-x · Cited by 84
“Surface expression of NKG2D on macrophages enables detection of DNA damaged cells, and stimulates secretion of inflammatory mediators to recruit other immune cells to the site [49].”
BackgroundBaba, T., Ishizu, A., Iwasaki, S., Suzuki, A., Tomaru, U., Ikeda, H., Yoshiki, T., & Kasahara, M. (2005) · Blood · doi:10.1182/blood-2005-06-2345 · Cited by 78
“NKG2D is the receptor previously shown to be expressed on NK cells, CTLs, and activated macrophages.(38) It binds to stress-inducible MHC class I molecules, MICA/B and ULBP/RAET1 in humans and RAE-1 (retinoic acid early inducible-1) in mice.”
BackgroundZimmer, J., Ioannidis, V., & Held, W. (2001) · Journal of Experimental Medicine · doi:10.1084/jem.194.10.1531 · Cited by 91
Herpesvirus Evasion of Natural Killer Cells
Pelsmaeker, S. D., Romero, N., Vitale, M., & Favoreel, H. W. (2018) · Journal of Virology · doi:10.1128/jvi.02105-17 · Cited by 76
Liu, S. D., Chalouni, C. M., Young, J. C., Junttila, T. T., Sliwkowski, M. X., & Lowe, J. B. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0125 · Cited by 80
“Cytotoxic properties also may be modulated by differences in factors such as the expression level of the target molecule (44), repertoire and expression levels of activating and/or inhibitory NK-cell ligands by the tumor cells (45, 46), and/or tumorborne adhesion molecules (47) on different types of cancer.”
BackgroundSelf-citationZhou, R., Wei, H., Sun, R., Zhang, J., & Tian, Z. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700822104 · Cited by 73
The immunoregulatory effects of Qa‐1
Lu, L., Werneck, M. B. F., & Cantor, H. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00418.x · Cited by 72
“Since activated CD4+ T cells may also express increased levels of ligands recognized by NK cell stimulatory receptors [includ- ing H-60 (59) and Rae1 (60)], the balance between stimulatory and inhibitory ligands displayed by CD4+ T cells can determine the fate of individual-activated CD4+ T cells.”
BackgroundInnate Immune Recognition and Suppression of Tumors
Hayakawa, Y., & Smyth, M. J. (2006) · Advances in cancer research · doi:10.1016/s0065-230x(06)95008-8 · Cited by 83
Natural Killer Cell Immune Responses
Yokoyama, W. M. (2005) · Immunologic Research · doi:10.1385/ir:32:1-3:317 · Cited by 88
Metadata
- Authors
- Diefenbach, A., Jamieson, A. M., Liu, S. D., Shastri, N., & Raulet, D. H.
- Affiliations
- University of California, Berkeley (US)
- Corresponding author
- Raulet, David H.
- Venue
- Nature Immunology
- Published
- 2000-08
- Volume
- 1
- Issue
- 2
- Pages
- 119-126
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W1603913234
- Cited by
- 878
- References
- 41
- Citations by year
- 2026: 9 · 2025: 4 · 2024: 17 · 2023: 12 · 2022: 28 · 2021: 17 · 2020: 23 · 2019: 18 · 2018: 29 · 2017: 31 · 2016: 17 · 2015: 23 · 2014: 24 · 2013: 28 · 2012: 38
- FWCI
- 18.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- NKG2D, NKG2D ligands, natural killer cells, macrophages, cancer cells, innate immunity, NK cell cytotoxicity, interferon-gamma, nitric oxide, TNF-α, MHC class I-related molecules, CD8+ T cells, expression cloning
- MeSH terms
- Animals, Chlorocebus aethiops, Cloning, Molecular, Cricetinae, Humans, Killer Cells, Natural, Ligands, Lymphocyte Activation, Macrophage Activation, Membrane Proteins, Mice, Inbred BALB C, Mice, Inbred C57BL, Receptors, Immunologic, Tumor Cells, Cultured, Minor Histocompatibility Antigens, CHO Cells, Macrophages, Peritoneal, COS Cells, Mice, Receptors, Natural Killer Cell, NK Cell Lectin-Like Receptor Subfamily K
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.